background rcid gemcitabineinduc hemolyt prem syndrome already describe adult sever approach employ treatment differ outcome one promise agent eculizumab monoclonal antibody direct c complement protein case present report yearly white boy medulloblastoma under highs chemotherapy craniospin iraqi afterward start painter gemcitabin oxaliplatin five cours present progress clinic worsen result system thrombot microangiopathi init treat rituximab without improv therefore therapy repeat cycle seven infos show gradual final complete remains concur prevent serious complemented vascular damage chemotherapyinduc mediator case 